ProQR Therapeutics vs uniQure
PRQR and QURE side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PRQR and QURE compare
uniQure grew revenue faster over the last twelve months (30.2% versus 11.4% for ProQR Therapeutics).
ProQR Therapeutics keeps more of each dollar of sales as profit, with a net margin of −229% compared with −1351% at uniQure.
ProQR Therapeutics scores higher on the StockData Score (7 against 4 for uniQure), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PRQR | QURE |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.4B |
| Share price | $1.15 | $20.78 |
| Change, 1 year | −47.0% | −30.5% |
| Change, 5 years | −84.0% | −27.9% |
| Beta (5Y) | 2.58 | 3.14 |
| Employees | 59 | 221 |
| StockData Score | ||
| Total score | 7 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 2 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 77.2× |
| P/B | – | 4.4× |
| FCF yield | – | −11.2% |
| Fair value | – | $6.42 |
| Margin of safety | – | −224% |
| Growth | ||
| Revenue growth (TTM) | 11.4% | 30.2% (better) |
| Revenue growth, 5Y average | – | −15.6% |
| Profitability | ||
| Gross margin | – | 92.5% |
| Operating margin | −233% (better) | −1072% |
| Net margin | −229% (better) | −1351% |
| FCF margin | −273% (better) | −865% |
| Return on equity | −57.4% (better) | −158% |
| Financial health | ||
| Debt / equity | 0.06 (better) | 0.15 |
| Interest coverage | – | −3.4× |
| Current ratio | 3.49 | 10.01 (better) |
| Altman Z-score | – | −0.51 |
| Piotroski F-score | 1 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 57.6% | 96.0% |
| Held by insiders | 37.8% | 2.1% |
| Insider net buying, 12 months | $1.3M (better) | −$20.2M |
| Short interest, % of float | – | 12.5% |
Go deeper
- PRQR stock overview
- PRQR income statement
- PRQR valuation and score
- QURE stock overview
- QURE income statement
- QURE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.